MAPT and Alzheimer disease: There have been reports of hyperphosphorylated tau, oxidative damage, aberrant mitochondrial activity, altered calcium homeostasis, and abnormal mitochondrial function in 3xTg-AD mice [52,53,54,55] and APP/PS1 mice [56], two mouse models of AD.